INNOSCIENCE (02577) elects Weiwei Luo as Chairman
INNOSCIENCE (02577) announced that the term of the Company's first Board of Directors has expired. In accordance with the relevant provisions of the Company Law and the Articles of Association, the Company held an employee representative meeting on September 23, 2026, at which Mr. Wu Lei was elected as an employee representative director of the second Board of Directors. Mr. Wu Lei, together with the other 8 non-employee representative directors elected at the extraordinary general meeting, will jointly constitute the second Board of Directors, with a term consistent with that of the second Board of Directors.
INNOSCIENCE (02577) announces that the term of the first board of directors of the Company has expired. In accordance with the relevant provisions of the Company Law and the Articles of Association, the Company held an employee representative meeting on September 23, 2026, at which Mr. Wu Lei was elected as an employee representative director of the second board of directors. Mr. Wu Lei, together with the other 8 non-employee representative directors elected at the extraordinary general meeting, will jointly constitute the second board of directors, with a term consistent with that of the second board of directors.
In accordance with the relevant provisions of the Company Law, the Articles of Association and the Listing Rules, the first meeting of the second board of directors was held on September 23, 2026, at which Dr. Weiwei Luo was elected as the chairman of the second board of directors, with a term commencing from the date of approval by the board of directors and ending on the date of expiration of the second board of directors.
Related Articles

Hangzhou Oxygen Plant Group (002430.SZ) plans to contribute RMB 50 million to invest in Star Ring Fusion Energy.

Jiangsu Sihuan Bioengineering (000518.SZ) plans to acquire an 80% stake in Changyuan Pharmaceutical for 160 million yuan.

SCHOLAR EDU (01769): Trustee purchases a total of 142,000 shares under the share award scheme
Hangzhou Oxygen Plant Group (002430.SZ) plans to contribute RMB 50 million to invest in Star Ring Fusion Energy.

Jiangsu Sihuan Bioengineering (000518.SZ) plans to acquire an 80% stake in Changyuan Pharmaceutical for 160 million yuan.

SCHOLAR EDU (01769): Trustee purchases a total of 142,000 shares under the share award scheme






